PMC:7417114 / 34067-34312 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T185","span":{"begin":0,"end":7},"obj":"Body_part"},{"id":"T186","span":{"begin":73,"end":76},"obj":"Body_part"},{"id":"T187","span":{"begin":233,"end":240},"obj":"Body_part"}],"attributes":[{"id":"A185","pred":"fma_id","subj":"T185","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A186","pred":"fma_id","subj":"T186","obj":"http://purl.org/sig/ont/fma/fma67095"},{"id":"A187","pred":"fma_id","subj":"T187","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"protein, ICP22, and through binding to ICP22 leads to phosphorylation of RNA polymerase II (61). Palbociclib, at least partly through inhibition of CDK6, inhibited HSV-1 replication in vitro (62), likely through blockade of cellular protein phos"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T301","span":{"begin":0,"end":7},"obj":"Chemical"},{"id":"T302","span":{"begin":88,"end":90},"obj":"Chemical"},{"id":"T303","span":{"begin":233,"end":240},"obj":"Chemical"}],"attributes":[{"id":"A301","pred":"chebi_id","subj":"T301","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A302","pred":"chebi_id","subj":"T302","obj":"http://purl.obolibrary.org/obo/CHEBI_74067"},{"id":"A303","pred":"chebi_id","subj":"T303","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"protein, ICP22, and through binding to ICP22 leads to phosphorylation of RNA polymerase II (61). Palbociclib, at least partly through inhibition of CDK6, inhibited HSV-1 replication in vitro (62), likely through blockade of cellular protein phos"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1182","span":{"begin":148,"end":152},"obj":"Gene"},{"id":"1189","span":{"begin":164,"end":169},"obj":"Species"}],"attributes":[{"id":"A1182","pred":"tao:has_database_id","subj":"1182","obj":"Gene:1021"},{"id":"A1189","pred":"tao:has_database_id","subj":"1189","obj":"Tax:10298"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"protein, ICP22, and through binding to ICP22 leads to phosphorylation of RNA polymerase II (61). Palbociclib, at least partly through inhibition of CDK6, inhibited HSV-1 replication in vitro (62), likely through blockade of cellular protein phos"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T117","span":{"begin":54,"end":69},"obj":"http://purl.obolibrary.org/obo/GO_0016310"}],"text":"protein, ICP22, and through binding to ICP22 leads to phosphorylation of RNA polymerase II (61). Palbociclib, at least partly through inhibition of CDK6, inhibited HSV-1 replication in vitro (62), likely through blockade of cellular protein phos"}

{"project":"2_test","denotations":[{"id":"32778962-18753202-84130674","span":{"begin":92,"end":94},"obj":"18753202"},{"id":"32778962-26542306-84130675","span":{"begin":192,"end":194},"obj":"26542306"}],"text":"protein, ICP22, and through binding to ICP22 leads to phosphorylation of RNA polymerase II (61). Palbociclib, at least partly through inhibition of CDK6, inhibited HSV-1 replication in vitro (62), likely through blockade of cellular protein phos"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T2197","span":{"begin":0,"end":245},"obj":"CHEBI:52217;CHEBI:52217"}],"text":"protein, ICP22, and through binding to ICP22 leads to phosphorylation of RNA polymerase II (61). Palbociclib, at least partly through inhibition of CDK6, inhibited HSV-1 replication in vitro (62), likely through blockade of cellular protein phos"}